26 November 2020

Patrick Jeurissen, Professor of Affordability of Care at the IQ healthcare department of the Radboudumc and scientific advisor to the Ministry of Health, Welfare and Sport, has been appointed as a member of the Scientific Advisory Board for the pan-European committee 'Health and Sustainable Development'. This committee will study healthcare policy in the light of pandemics in the coming year.

This independent committee was convened by the European branch of the World Health Organization (WHO). The committee will review health care policies and systems and look at them in the broader context of sustainable development strategies.

Increase awareness of possible pandemics

In the coming year, the committee will study health care policy in relation to pandemics. The committee's tasks are as follows:

  • To make a comprehensive rethink for setting priorities in economic and social policy;
  • to identify the challenges and opportunities facing health and social care systems in the 53 member states of the WHO European Region;
  • Make recommendations and build consensus on raising awareness of potential pandemic and pandemic-like threats;
  • Improve health systems in terms of structure and investment;
  • Redefine governance and strengthen resilience and capacity of countries to anticipate and innovate.

Scientific Advisory Board

The committee will bring together knowledge and wisdom from a continent-wide network of, among others, leaders, policy makers and scientists, and will be supported in this task by a Scientific Advisory Board (SAB) consisting of academics and policy officers.

Patrick Jeurissen, together with the other members of the WA, will provide the committee with a scientific basis for collecting relevant scientific literature. In addition, the WA will present priorities and options to policy makers for investments in health and social systems. This to support economic growth and promote cohesion in societies.


Related news items

Radiation boost lowers risk of prostate cancer recurrence

21 January 2021

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.

read more

New research through grants for Radboudumc researchers

14 January 2021

Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.

read more

Cooling vests alleviate perceptual heat strain perceived by COVID-19 nurses

11 January 2021

Wearing cooling vests during a COVID-19 shift ensures that nurses experience less heat during their work. The cooling vests offer such effective cooling that they are now part of the standard work clothing for nurses in the COVID nursing departments at Radboudumc.

read more

Hermesdorf Prizes for COVID-19 research team and Charlotte Bekker

7 January 2021

The entire COVID-19 research team at Radboudumc, which includes Frank van de Veerdonk, Mihai Netea, Roger Brüggemann, Leo Joosten and Alexander Hoischen, will receive the 2020 Hermesdorf Prize. Charlotte Bekker will be awarded the Hermesdorf Talent Prize.

read more

A full blood count of COVID-19 patients can predict disease severity

22 December 2020

International research led by the Radboudumc makes it easier for healthcare providers to estimate the expected clinical picture.

read more

Last call for nominations RIHS Awards 2020

15 December 2020

RIHS researchers are invited to propose candidates for the RIHS PhD Award, the Societal Impact Award, the Science Award, the Supervisor of the year Award, and the novel RIHS Patient Involvement Award. Deadline for submission is 19 January 2021.

read more